Cargando…

Efficacy and Safety of Eplerenone for Treating Chronic Kidney Disease: A Meta-Analysis

BACKGROUND: In recent years, a large amount of clinical evidence and animal experiments have demonstrated the unique advantages of mineralocorticoid receptor antagonists (MRA) for treating chronic kidney disease (CKD). AIMS: Accordingly, the present study aimed to systematically assess the second-ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Honglei, Cao, Mengdie, Sun, Yao, Jin, Xingqian, Zhao, Xiaodong, Cong, Xiangguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019978/ https://www.ncbi.nlm.nih.gov/pubmed/36938116 http://dx.doi.org/10.1155/2023/6683987

Ejemplares similares

Efficacy and safety of eplerenone treatment for patients with diabetic nephropathy: A meta-analysis
por: Hu, Honglei, et al.
Publicado: (2022)

Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A
por: Bertocchio, Jean-Philippe, et al.
Publicado: (2016)

Eplerenone Treatment in Chronic Central Serous Chorioretinopathy
por: Iqbal, Faisal, et al.
Publicado: (2021)

Rationale for treating oedema in Duchenne muscular dystrophy with eplerenone
por: LEHMANN-HORN, FRANK, et al.
Publicado: (2012)

Eplerenone ethanol solvate
por: Yang, Qian, et al.
Publicado: (2008)

Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone
por: Anderson, William J., et al.
Publicado: (2022)

Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy
por: Sadda, Srinivas R.
Publicado: (2020)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
por: Kapoor, Kapil G., et al.
Publicado: (2015)

Eplerenone: The Multifaceted Drug in Cardiovascular Pharmacology
por: Pradhan, Akshyaya, et al.
Publicado: (2020)

Choriocapillaris Reperfusion in Resolved Chronic Central Serous Chorioretinopathy Treated with Eplerenone: Long-Term Effects on the Fellow Eye
por: Viggiano, Pasquale, et al.
Publicado: (2023)

Eplerenone Attenuates Fibrosis in the Contralateral Kidney of UUO Rats by Preventing Macrophage-to-Myofibroblast Transition
por: Xiong, Yunzhao, et al.
Publicado: (2021)

Eplerenone Attenuates Pulse Wave Reflection in Chronic Kidney Disease Stage 3–4 - A Randomized Controlled Study
por: Boesby, Lene, et al.
Publicado: (2013)

Eplerenone use in primary aldosteronism during pregnancy
por: Gunganah, Kirun, et al.
Publicado: (2015)

Safety and Antihypertensive Effect of Selara® (Eplerenone): Results from a Postmarketing Surveillance in Japan
por: Takahashi, Shoko, et al.
Publicado: (2016)

A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
por: Filippatos, Gerasimos, et al.
Publicado: (2016)

Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone – a case report
por: Venkatesh, Ramesh, et al.
Publicado: (2020)

Efficacy of mineralocorticoid receptor antagonism in the acute myocardial infarction phase: eplerenone versus spironolactone
por: Fraccarollo, Daniela, et al.
Publicado: (2015)

Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy
por: Nakano, Yujiro, et al.
Publicado: (2018)

Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability
por: Khan, Muhammad Ayub, et al.
Publicado: (2021)

Effect of oral eplerenone in anatomical and functional improvement in patients with chronic central serous chorioretinopathy
por: Farooq, Omer, et al.
Publicado: (2019)

Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study
por: Moein, Hamid-Reza, et al.
Publicado: (2019)

Routine Clinical Practice Treatment Outcomes of Eplerenone in Acute and Chronic Central Serous Chorioretinopathy
por: Fasler, Katrin, et al.
Publicado: (2021)

Possible dose-dependent effect of eplerenone on intraocular pressure
por: Razavi, Seyedeh Mehrsa Sadat, et al.
Publicado: (2023)

Efficacy and Safety of Tanshinone for Chronic Kidney Disease: A Meta-Analysis
por: Zhou, Yao, et al.
Publicado: (2020)

Moderate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over Study
por: Boesby, Lene, et al.
Publicado: (2011)

Efficacy and Safety of Salvia miltiorrhiza for Treating Chronic Kidney Diseases: A Systematic Review and Meta-Analysis
por: Zhang, Wei, et al.
Publicado: (2022)

Adrenal gland inclusions in patients treated with aldosterone antagonists (Spironolactone/Eplerenone): incidence, morphology, and ultrastructural findings
por: Patel, Kishan A, et al.
Publicado: (2014)

The Influence of Ionizing Radiation, Temperature, and Light on Eplerenone in the Solid State
por: Dettlaff, Katarzyna, et al.
Publicado: (2014)

Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature
por: Chatziralli, Irini, et al.
Publicado: (2018)

Effect of augmented reality navigation technology on perioperative safety in partial nephrectomies: A meta-analysis and systematic review
por: Cheng, Cong, et al.
Publicado: (2023)

Safety and Efficacy of Roxadustat for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis and Trial Sequential Analysis
por: Liu, Chao, et al.
Publicado: (2021)

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
por: Lee, Dawn, et al.
Publicado: (2014)

Degradation Pathway for Eplerenone by Validated Stability Indicating UP-LC Method
por: Sudhakar Babu, Kondru, et al.
Publicado: (2012)

Database Analysis of Eplerenone Use in Japanese Hypertensive Patients in Clinical Practice
por: Takahashi, Shoko, et al.
Publicado: (2019)

Synthesis and Physicochemical Characterization of the Process-Related Impurities of Eplerenone, an Antihypertensive Drug
por: Dams, Iwona, et al.
Publicado: (2017)

Cost-effectiveness of Eplerenone in treatment of cardiovascular diseases: a systematic review
por: Mobaraki, Hossein, et al.
Publicado: (2017)

The effect of eplerenone on the renin‐angiotensin‐aldosterone system of rats with thyroid dysfunction
por: Dizaye, Kawa, et al.
Publicado: (2019)

Real-world practice patterns of eplerenone use for central serous chorioretinopathy
por: Venkatesh, Ramesh, et al.
Publicado: (2023)

Efficacy and safety of febuxostat for treating hyperuricemia in patients with chronic kidney disease and in renal transplant recipients: A systematic review and meta-analysis
por: Liu, Xuzhong, et al.
Publicado: (2018)

Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece
por: Athanasakis, Kostas, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tkj8ae3se427i8hcm33kgddjar